Yu P - Search Results

1

CD147 Facilitates the Pathogenesis of Psoriasis through Glycolysis and H3K9me3 Modification in Keratinocytes.

Chen C, Yi X, Liu P, Li J, Yan B, Zhang D, Zhu L, Yu P, Li L, Zhang J, Kuang Y, Zhao S, Zhu W, Peng C, Chen X. Chen C, et al. Among authors: yu p. Research (Wash D C). 2023 Jun 8;6:0167. doi: 10.34133/research.0167. eCollection 2023. Research (Wash D C). 2023. PMID: 37303600 Free PMC article.

2

Pyroptosis: mechanisms and diseases.

Yu P, Zhang X, Liu N, Tang L, Peng C, Chen X. Yu P, et al. Signal Transduct Target Ther. 2021 Mar 29;6(1):128. doi: 10.1038/s41392-021-00507-5. Signal Transduct Target Ther. 2021. PMID: 33776057 Free PMC article. Review.

3

ERAP2 as a potential biomarker for predicting gemcitabine response in patients with pancreatic cancer.

Yu P, Luo S, Cai J, Li J, Peng C. Yu P, et al. Aging (Albany NY). 2022 Oct 8;14(19):7941-7958. doi: 10.18632/aging.204324. Epub 2022 Oct 8. Aging (Albany NY). 2022. PMID: 36214762 Free PMC article.

4

The traditional chinese medicine monomer Ailanthone improves the therapeutic efficacy of anti-PD-L1 in melanoma cells by targeting c-Jun.

Yu P, Wei H, Li K, Zhu S, Li J, Chen C, Zhang D, Li Y, Zhu L, Yi X, Liu N, Liu P, Zhao S, Chen X, Peng C. Yu P, et al. J Exp Clin Cancer Res. 2022 Dec 15;41(1):346. doi: 10.1186/s13046-022-02559-z. J Exp Clin Cancer Res. 2022. PMID: 36522774 Free PMC article.

5

A novel ribosomal protein S6 kinase 2 inhibitor attenuates the malignant phenotype of cutaneous malignant melanoma cells by inducing cell cycle arrest and apoptosis.

Li Y, Yu P, Long J, Tang L, Zhang X, Zhou Z, Cao D, Su J, Chen X, Peng C. Li Y, et al. Among authors: yu p. Bioengineered. 2022 May;13(5):13555-13570. doi: 10.1080/21655979.2022.2080364. Bioengineered. 2022. PMID: 36700473 Free PMC article.

6

A new perspective in pyroptosis: lifting the veil on GSDMA activation.

Yu P, Chen X, Peng C. Yu P, et al. Front Med. 2023 Jun;17(3):581-583. doi: 10.1007/s11684-022-0971-9. Epub 2023 Feb 23. Front Med. 2023. PMID: 36813981 No abstract available.

7

PTGS2: A potential immune regulator and therapeutic target for chronic spontaneous urticaria.

Chen Y, Jian X, Zhu L, Yu P, Yi X, Cao Q, Wang J, Xiong F, Li J. Chen Y, et al. Among authors: yu p. Life Sci. 2024 May 1;344:122582. doi: 10.1016/j.lfs.2024.122582. Epub 2024 Mar 19. Life Sci. 2024. PMID: 38514006

8

Identification of HMGCR as the anticancer target of physapubenolide against melanoma cells by in silico target prediction.

Wang HY, Yu P, Chen XS, Wei H, Cao SJ, Zhang M, Zhang Y, Tao YG, Cao DS, Qiu F, Cheng Y. Wang HY, et al. Among authors: yu p. Acta Pharmacol Sin. 2022 Jun;43(6):1594-1604. doi: 10.1038/s41401-021-00745-x. Epub 2021 Sep 29. Acta Pharmacol Sin. 2022. PMID: 34588618 Free PMC article.

9

UCH-L1-mediated Down-regulation of Estrogen Receptor α Contributes to Insensitivity to Endocrine Therapy for Breast Cancer.

Chen XS, Wang KS, Guo W, Li LY, Yu P, Sun XY, Wang HY, Guan YD, Tao YG, Ding BN, Yin MZ, Ren XC, Zhang Y, Chen CS, Ye YC, Yang JM, Cheng Y. Chen XS, et al. Among authors: yu p. Theranostics. 2020 Jan 1;10(4):1833-1848. doi: 10.7150/thno.39814. eCollection 2020. Theranostics. 2020. PMID: 32042339 Free PMC article.

10

PKM2-c-Myc-Survivin Cascade Regulates the Cell Proliferation, Migration, and Tamoxifen Resistance in Breast Cancer.

Yu P, Li AX, Chen XS, Tian M, Wang HY, Wang XL, Zhang Y, Wang KS, Cheng Y. Yu P, et al. Front Pharmacol. 2020 Sep 8;11:550469. doi: 10.3389/fphar.2020.550469. eCollection 2020. Front Pharmacol. 2020. PMID: 33013387 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8,559 results

Search Page

Filters